Latest Eric Topol Stories
WASHINGTON, Dec. 6, 2012 /PRNewswire/ -- On December 6, AACC's Clinical Chemistry Journal will release a podcast with Dr. Eric Topol on "lab- on-a-chip" technology - technology that will create a paradigm shift in how healthcare is delivered to patients. With lab-on-a-chip technology, smartphones will bring the laboratory to the patient, instead of the patient being WHAT: brought to the...
LOS ANGELES, October 3, 2012 /PRNewswire/ -- MedTech Cardio 2012 (http://www.medtechcardio.com) is the only industry forum focused on cardiovascular device design and manufacturing. The conference takes place over two days on October 30 and 31, 2012 at the Minneapolis Convention Center, alongside the MD&M Minneapolis exposition [http://www.mdmminn.com ] for medical devices. MedTech Cardio 2012 [http://www.medtechcardio.com ] is proud to host Dr. Dave Albert, a...
SAN DIEGO, Oct. 3, 2012 /PRNewswire/ -- Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine. The funding will advance clinical trials of cutting-edge wireless biosensor systems,...
In this time of radical innovation in medicine, it is all the more important to "treat the patient," Dr. Eric Topol, a leader in the field of advancing health care through technology, advised the graduating class of Baylor College of Medicine Tuesday. "Even though we have this exciting time in medicine – radical innovation – we need doctors with compassion, with empathy and bedside manner who are great communicators, who have healing touch," he told the graduates. "And those qualities...
SAN DIEGO, May 11, 2012 /PRNewswire/ -- A study conducted at Scripps Health has found that a novel new heart monitoring device helped emergency room patients avoid unnecessary follow-up care. Scripps Health electrophysiologist Steven Higgins, MD, presented findings of the study titled, "Prevalence of Arrhythmias in Emergency Department Patients Discharged Using a Novel Ambulatory Cardiac Monitor," today at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston....
LOS ANGELES, May 7, 2012 /PRNewswire/ -- MD+DI (Medical Device and Diagnostic Industry), UBM Canon's leading brand providing the medical device industry with the latest news, information, and in-depth analysis, speaks with Cardiologist Eric Topol, MD who was recently honored as the medtech industry's most influential physician executive in the United States by Modern Healthcare magazine. (Photo: http://photos.prnewswire.com/prnh/20120507/LA01287) (Logo:...
A new blood test developed to predict heart attacks as much as two weeks in advance could be a savior to more than 2.5 million Americans at risk, medical news site MyHealthNewsDaily reports. The test, which measures circulating endothelial cells (CECs) in the blood, was used in a study of 50 patients led by Scripps Translational Science Institute (STSI) – a collaborative program between Scripps Health and the Scripps Research Institute (SRI). CECs in heart attack patients are larger...
SAN DIEGO, March 21, 2012 /PRNewswire/ -- New findings from a landmark research study led by Scripps Translational Science Institute (STSI) - a collaborative program between Scripps Health and The Scripps Research Institute (TSRI) - shows a promising new blood test may be useful in helping doctors predict who is at risk for an imminent heart attack. (Photo: http://photos.prnewswire.com/prnh/20120321/LA74303) Results of the study titled, "Characterization of Circulating...
RARITAN, N.J., March 21, 2012 /PRNewswire/ -- Veridex, LLC today announced the publication of a new, investigational study published this week in Science Translational Medicine that lays the foundation for research that may potentially result in a blood test to determine imminent risk of heart attack within high-risk populations. The study, "Characterization of Circulating Endothelial Cells in Acute Myeloid Infarction," was led by Eric J. Topol, M.D., director of the Scripps...
New findings from a research study led by physicians at Scripps Health reveal that the drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications. Initial results from the BRIDGE trial will be published Jan. 18, 2012, in an article in the Journal of the American Medical Association...
